Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery

被引:33
作者
Gurfinkel, Enrique P.
de la Hoz, Ricardo Perez
Brito, Viviana M.
Duronto, Ernesto
Dabbous, Omar H.
Gore, Joel M.
Anderson, Frederick A., Jr.
机构
[1] ICyCC Fdn Favaloro, RA-1093 Buenos Aires, DF, Argentina
[2] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina
[3] Univ Massachusetts, Sch Med, Worcester, MA USA
关键词
coronary artery bypass grafting; angina; infarction; prevention; angioplasty;
D O I
10.1016/j.ijcard.2006.07.058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We evaluated the association between invasive and non- invasive management and hospital and 6- month outcomes in patients with a prior coronary artery bypass graft ( CABG) who experienced an acute coronary syndrome. Methods: Data were analysed from patients with a prior CABG who developed an acute coronary syndrome and were enrolled in the Global Registry of Acute Coronary Events. From 44,991 patients included in the study, 3853 fulfilled the inclusion criteria. Of these, 3356 received non- invasive treatment approaches while 497 underwent invasive treatment ( percutaneous coronary intervention [ PCI] within 48 h of admission). Results: The primary composite endpoint of death, non- fatal myocardial infarction, and recurrent ischaemia during hospitalization was similar in patients in the non- invasive and invasive groups ( 31% vs 30%, respectively; P= 0.53). The rates of hospital mortality ( non- invasive 3.4% vs invasive 3.2%) and non- fatal myocardial infarction ( 3.4% vs 5.1%, respectively) were similar. At 6- month follow- up, the mortality rate was 6.5% in the non- invasive group vs 3.4% in the invasive group ( P<0.02); the combined endpoint of death or myocardial infarction was lower in the invasive group ( P<0.01). Multivariable analysis showed that, at 6- month follow- up, the combined endpoint of death, nonfatal myocardial infarction, and rehospitalization for heart disease was similar ( P= 0.10). A greater proportion of patients in the invasive group required unscheduled diagnostic and therapeutic invasive procedures compared with those in the non- invasive group ( angiography 15.4% vs 8.1%; PCI 10% vs 5.0%; both P<0.001). Conclusions: The results from this observational study show no statistically significant differences in hospital outcomes between acute coronary syndrome patients with a prior CABG who undergo invasive or non- invasive treatment. Invasively treated patients experienced higher rates of readmission and additional cardiac procedures than non- invasively treated patients but a lower incidence of cardiovascular complications at 6 months. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 24 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project:: A multinational registry of patients hospitalized with acute coronary syndromes [J].
Agnelli, G ;
Avezum, A ;
Brieger, D ;
Budaj, A ;
Cannon, CP ;
Goldberg, RJ ;
Goodman, S ;
Gulba, DC ;
Granger, C ;
Kennelly, BM ;
Gurfinkel, E ;
López-Sendón, J ;
Klein, W ;
Montalescot, G ;
Van de Werf, F .
AMERICAN HEART JOURNAL, 2001, 141 (02) :190-199
[3]   Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes [J].
Antman, EM ;
Tanasijevic, MJ ;
Thompson, B ;
Schactman, M ;
McCabe, CH ;
Cannon, CP ;
Fischer, GA ;
Fung, AY ;
Thompson, C ;
Wybenga, D ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1342-1349
[4]   Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J].
Bertrand, ME ;
Simoons, ML ;
Fox, KAA ;
Wallentin, LC ;
Hamm, CW ;
McFadden, E ;
De Feyter, PJ ;
Specchia, G ;
Ruzyllo, W .
EUROPEAN HEART JOURNAL, 2002, 23 (23) :1809-1840
[5]  
BODEN WE, 2003, MINERVA CARDIOANGIOL, V51, P1447
[6]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[7]   The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study [J].
Cannon, CP ;
McCabe, CH ;
Stone, PH ;
Rogers, WJ ;
Schactman, M ;
Thompson, BW ;
Pearce, DJ ;
Diver, DJ ;
Kells, C ;
Feldman, T ;
Williams, M ;
Gibson, RS ;
Kronenberg, MW ;
Ganz, LI ;
Anderson, HV ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :133-140
[8]   Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction - Observations from the TIMI 14 trial [J].
de Lemos, JA ;
Antman, EM ;
Gibson, CM ;
McCabe, CH ;
Giugliano, RP ;
Murphy, SA ;
Coulter, SA ;
Anderson, K ;
Scherer, J ;
Frey, MJ ;
Van der Wieken, R ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 2000, 101 (03) :239-243
[9]   Early invasive versus selectively invasive management for acute coronary syndromes [J].
de Winter, RJ ;
Windhausen, F ;
Cornel, JH ;
Dunselman, PHJM ;
Janus, CL ;
Bendermacher, PEF ;
Michels, HR ;
Sanders, GT ;
Tijssen, JGP ;
Verheugt, FWA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11) :1095-1104
[10]   Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational study [J].
Eagle, KA ;
Kline-Rogers, E ;
Goodman, SG ;
Gurfinkel, EP ;
Avezum, A ;
Flather, MD ;
Granger, CB ;
Erickson, S ;
White, K ;
Steg, PG .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (02) :73-81